DK1026263T3 - Oligonukleotidprimere til omvendt transkription til effektiv detektering af HIV-1 og HIV-2 og fremgangsmåder til anvendelse deraf - Google Patents

Oligonukleotidprimere til omvendt transkription til effektiv detektering af HIV-1 og HIV-2 og fremgangsmåder til anvendelse deraf

Info

Publication number
DK1026263T3
DK1026263T3 DK00300792T DK00300792T DK1026263T3 DK 1026263 T3 DK1026263 T3 DK 1026263T3 DK 00300792 T DK00300792 T DK 00300792T DK 00300792 T DK00300792 T DK 00300792T DK 1026263 T3 DK1026263 T3 DK 1026263T3
Authority
DK
Denmark
Prior art keywords
hiv
methods
reverse transcription
oligonucleotide primers
effective detection
Prior art date
Application number
DK00300792T
Other languages
English (en)
Inventor
John A Puskas
Keming Song
Jeffrey M Linnen
David R Patterson
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Application granted granted Critical
Publication of DK1026263T3 publication Critical patent/DK1026263T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK00300792T 1999-02-02 2000-02-01 Oligonukleotidprimere til omvendt transkription til effektiv detektering af HIV-1 og HIV-2 og fremgangsmåder til anvendelse deraf DK1026263T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11841799P 1999-02-02 1999-02-02

Publications (1)

Publication Number Publication Date
DK1026263T3 true DK1026263T3 (da) 2008-09-08

Family

ID=22378462

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00300792T DK1026263T3 (da) 1999-02-02 2000-02-01 Oligonukleotidprimere til omvendt transkription til effektiv detektering af HIV-1 og HIV-2 og fremgangsmåder til anvendelse deraf

Country Status (13)

Country Link
US (1) US6303293B1 (da)
EP (1) EP1026263B1 (da)
JP (1) JP2000342274A (da)
KR (1) KR100901084B1 (da)
CN (1) CN1186455C (da)
AT (1) ATE397099T1 (da)
AU (1) AU761066B2 (da)
CA (1) CA2295920C (da)
DE (1) DE60038993D1 (da)
DK (1) DK1026263T3 (da)
ES (1) ES2306648T3 (da)
NO (1) NO327727B1 (da)
PT (1) PT1026263E (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7225019B2 (en) 1996-04-30 2007-05-29 Medtronic, Inc. Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure
US6449507B1 (en) 1996-04-30 2002-09-10 Medtronic, Inc. Method and system for nerve stimulation prior to and during a medical procedure
US8036741B2 (en) 1996-04-30 2011-10-11 Medtronic, Inc. Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure
US7269457B2 (en) 1996-04-30 2007-09-11 Medtronic, Inc. Method and system for vagal nerve stimulation with multi-site cardiac pacing
US6479523B1 (en) * 1997-08-26 2002-11-12 Emory University Pharmacologic drug combination in vagal-induced asystole
US7840278B1 (en) 1999-06-25 2010-11-23 Puskas John D Devices and methods for vagus nerve stimulation
AU781934B2 (en) * 1999-07-09 2005-06-23 Gen-Probe Incorporated Detection of HIV-1 by nucleic acid amplification
CA2318730C (en) * 1999-09-20 2008-01-22 Ortho-Clinical Diagnostics, Inc. A method for reverse transcribing rna isolated in dry form
US6487446B1 (en) 2000-09-26 2002-11-26 Medtronic, Inc. Method and system for spinal cord stimulation prior to and during a medical procedure
JP4202750B2 (ja) * 2000-10-23 2008-12-24 ジェン−プローブ・インコーポレーテッド ヒト免疫不全ウイルス２（ｈｉｖ−２）を検出するための組成物および方法
ATE478968T1 (de) * 2003-12-19 2010-09-15 Gen Probe Inc Zusammensetzungen, verfahren und kits zum nachweis der nukleinsäuren von hiv-1 und hiv-2
CN100340673C (zh) * 2005-02-03 2007-10-03 上海科华生物工程股份有限公司 人类免疫缺陷病毒hiv－1核酸扩增－荧光定量检测试剂盒
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
US8888699B2 (en) 2010-04-29 2014-11-18 Medtronic, Inc. Therapy using perturbation and effect of physiological systems
US8639327B2 (en) 2010-04-29 2014-01-28 Medtronic, Inc. Nerve signal differentiation in cardiac therapy
US8620425B2 (en) 2010-04-29 2013-12-31 Medtronic, Inc. Nerve signal differentiation in cardiac therapy
US8781582B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
US8718763B2 (en) 2011-01-19 2014-05-06 Medtronic, Inc. Vagal stimulation
US8781583B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
US8725259B2 (en) 2011-01-19 2014-05-13 Medtronic, Inc. Vagal stimulation
US8706223B2 (en) 2011-01-19 2014-04-22 Medtronic, Inc. Preventative vagal stimulation
ES2667425T3 (es) 2011-06-10 2018-05-10 Oregon Health & Science University Glucoproteínas y vectores recombinantes de CMV
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
JP5553323B2 (ja) * 2012-01-25 2014-07-16 独立行政法人科学技術振興機構 Ｈｉｖ検出キット、及びｈｉｖ検出方法
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
ES2800474T3 (es) * 2014-05-27 2020-12-30 Univ Paris Descartes Método in vitro para la detección y la cuantificación del VIH-2
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
JP7483373B2 (ja) * 2016-07-29 2024-05-15 ジュノー セラピューティクス インコーポレイテッド 複製可能ウイルスの存在または非存在を評価するための方法
WO2018045425A1 (en) * 2016-09-07 2018-03-15 St Vincent's Hospital Sydney Limited Methods of detecting lentivirus
CN106498095A (zh) * 2016-11-14 2017-03-15 湖南圣湘生物科技有限公司 一种人类免疫性缺陷病毒2型核酸检测试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2275451T3 (es) 1989-06-02 2009-02-16 Institut Pasteur Secuencias nucleotidicas procedentes del genoma de los retrovirus del tipo vih-1,vih-2 y siv, y sus aplicaciones especialmente para la amplificacion de los genomas de estos retrovirus y para el diagnostico in vitro de las infecciones debidas a estos virus.
US5478724A (en) 1991-08-16 1995-12-26 The Rockefeller University Lentivirus-specific nucleotide probes and methods of use
JP3277045B2 (ja) 1992-10-06 2002-04-22 デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング Ｈｉｖ−グループのレトロウイルスおよびその使用
US5599662A (en) * 1995-02-17 1997-02-04 Hoffmann-La Roche Inc. Oliconucleotide primers and probes for the detection of HIV-1
US5962665A (en) 1997-06-16 1999-10-05 Abbott Laboratories Nucleic acid primers and probes for detecting HIV-1 and HIV-2
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2

Also Published As

Publication number Publication date
AU761066B2 (en) 2003-05-29
EP1026263B1 (en) 2008-05-28
US6303293B1 (en) 2001-10-16
NO20000513D0 (no) 2000-02-01
ATE397099T1 (de) 2008-06-15
KR20010014470A (ko) 2001-02-26
CA2295920C (en) 2013-10-29
ES2306648T3 (es) 2008-11-16
CA2295920A1 (en) 2000-08-02
NO327727B1 (no) 2009-09-14
EP1026263A3 (en) 2000-10-11
AU1482900A (en) 2000-08-03
CN1271020A (zh) 2000-10-25
JP2000342274A (ja) 2000-12-12
DE60038993D1 (de) 2008-07-10
EP1026263A2 (en) 2000-08-09
PT1026263E (pt) 2008-08-27
NO20000513L (no) 2000-08-03
KR100901084B1 (ko) 2009-06-08
CN1186455C (zh) 2005-01-26

Similar Documents

Publication Publication Date Title
NO20000513L (no) Oligonukleotidreverstranskripsjonsprimere for effektiv detektering av HIV-1 og HIV-2 og metoder for anvendelse derav
DK1026262T3 (da) Oligonukleotidprimere til effektiv detektering af hepatitis C-virus (HCV) og fremgangsmåder til anvendelse deraf
DK0887427T3 (da) Amplifikation og detektion af HIV-1 og/eller HIV-2
FR16C0028I2 (fr) Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques
DK0915648T3 (da) Fremgangsmåder og præparater til selektiv modificering af nukleinsyrer
DK1515752T3 (da) ACE2-aktivering til behandling af hjerte-, lunge- og nyresygdomme og hypertension
DK1409544T3 (da) Humane DR4-antistoffer og anvendelser deraf
TR199701669A1 (xx) Deri preparasyonu i�in bile�imler.
ATE421999T1 (de) Nachweis von hiv-1 durch amplifizierung von nukleinsäuren
DK1790728T3 (da) Billeddannelse, diagnose og behandling af sygdom
NO20000514L (no) Oligonukleotidprimere for effektiv multipleksdeteksjon av Hepatitt C-virus (HCV) og human immunosviktvirus (HIV) og metoder for anvendelse derav
EP4365311A3 (en) Methods of detecting lentivirus
DE60132924D1 (de) Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
WO2002022076A3 (en) Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
DK1406927T3 (da) Glycopeptider, fremstilling og anvendelse deraf til diagnosticering eller terapeutisk behandling af dissemineret sklerose
ATE305522T1 (de) Nachweis von humanen papillomviren
EP1407042A4 (en) DEVICE AND METHODS FOR MONITORING ANTIRETROVIRAL THERAPY INHIBITING PROTEASE AND DETERMINING THERAPEUTIC DECISIONS IN THE TREATMENT OF HIV / AIDS
DK1301637T3 (da) DNA-vacciner, der koder for HIV accessoriske proteiner
WO2004016228A3 (en) HTLV-I p30II AND p12I PROTEINS AS THERAPEUTIC TARGETS IN HTVL-I INFECTED INDIVIDUALS
ATE198602T1 (de) Makrocyclische difluorostatonderivate als antivirale mittel
TR200000435T2 (tr) Bulaşıcı akdeniz humması geni.
CY1108543T1 (el) Εμβολια dna που κωδικοποιουν βοηθητικες πρωτεϊνες του hiv